WallStreetZenWallStreetZen

NYSEMKT: VTAK
Catheter Precision Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their VTAK stock forecasts and price targets.

Forecast return on equity

Is VTAK forecast to generate an efficient return?

Company
N/A
Industry
22.5%
Market
-18.68%

Forecast return on assets

Is VTAK forecast to generate an efficient return on assets?

Company
N/A
Industry
11.91%

VTAK earnings per share forecast

What is VTAK's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$119.77
Avg 2 year Forecast
-$60.84

VTAK vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
VTAK$2.79N/AN/A
TIVC$3.12N/AN/A
BBLG$2.16N/AN/A
AEMD$1.55$28.75+1,754.84%Buy
IVF$1.01N/AN/A
View Top Medical Device Stocks

Catheter Precision Stock Forecast FAQ

What is VTAK's earnings growth forecast for 2025-2026?

(NYSEMKT: VTAK) Catheter Precision's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 17.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.77%.

Catheter Precision's earnings in 2025 is -$24,060,000.On average, 1 Wall Street analyst forecast VTAK's earnings for 2025 to be -$147,051,627, with the lowest VTAK earnings forecast at -$147,051,627, and the highest VTAK earnings forecast at -$147,051,627.

In 2026, VTAK is forecast to generate -$74,692,865 in earnings, with the lowest earnings forecast at -$74,692,865 and the highest earnings forecast at -$74,692,865.

If you're new to stock investing, here's how to buy Catheter Precision stock.

What is VTAK's forecast return on equity (ROE) for 2025-2027?

(NYSEMKT: VTAK) forecast ROE is N/A, which is considered weak.

What is VTAK's Earnings Per Share (EPS) forecast for 2025-2026?

(NYSEMKT: VTAK) Catheter Precision's current Earnings Per Share (EPS) is -$2.85. On average, analysts forecast that VTAK's EPS will be -$119.77 for 2025, with the lowest EPS forecast at -$119.77, and the highest EPS forecast at -$119.77. In 2026, VTAK's EPS is forecast to hit -$60.84 (min: -$60.84, max: -$60.84).

What is VTAK's forecast return on assets (ROA) for 2025-2027?

(NYSEMKT: VTAK) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 11.91%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.